Q1 2026 · 13F-HR
ADAR1 Capital Management, LLCholdings as filed
Filed 2026-05-18 · accession 0001940272-26-000005
$1.70B
Reported value
310
Positions
2026-03-31
Period end
The Brief · ADAR1 Capital Management, LLC · Q1 2026
AI · grounded in 13F
ADAR1 Capital Management, LLC closed its position in Avidity Biosciences Inc, reducing exposure by $39.4M. The fund established new positions in BEAM for $34.5M and VIR for $24.6M. Additionally, the manager increased its stake in DNLI by 3,490.9% and CRNX by 268.3%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 00370M103 | ABVX | ABIVAX SA | $155.2M | 9.14% | 1,394,019 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $104.8M | 6.17% | 994,119 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $91.0M | 5.36% | 3,285,906 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $66.5M | 3.92% | 2,679,010 | Common | SOLE |
| 78462F103 | SPY | STATE STR SPDR S&P 500 ETF T | $49.4M | 2.91% | 75,940 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $48.2M | 2.84% | 914,699 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $41.7M | 2.45% | 632,556 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $41.4M | 2.44% | 1,139,331 | Common | SOLE |
| 02072L565 | BOXX | EA SERIES TRUST | $39.2M | 2.31% | 337,125 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $35.9M | 2.12% | 1,871,455 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $34.5M | 2.03% | 1,446,375 | Common | SOLE |
| 98887Q104 | ZLAB | ZAI LAB LTD | $26.8M | 1.58% | 1,425,367 | Common | SOLE |
| 81734D104 | SEPN | SEPTERNA INC | $26.2M | 1.54% | 1,089,818 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $24.6M | 1.45% | 2,744,714 | Common | SOLE |
| 23306J309 | DBVT | DBV TECHNOLOGIES S A | $21.2M | 1.25% | 1,012,866 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $21.0M | 1.24% | 3,789,132 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $20.9M | 1.23% | 405,197 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $20.0M | 1.18% | 407,273 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $18.4M | 1.08% | 211,450 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $17.1M | 1.00% | 338,323 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC. | $16.0M | 0.94% | 3,410,190 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $15.4M | 0.90% | 1,581,443 | Common | SOLE |
| 80105N105 | SNY | SANOFI SA | $15.3M | 0.90% | 316,939 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $15.1M | 0.89% | 259,137 | Common | SOLE |
| 61023L207 | MNPR | MONOPAR THERAPEUTICS INC | $14.5M | 0.85% | 264,278 | Common | SOLE |
| 03879J100 | ABUS | ARBUTUS BIOPHARMA CORP | $14.1M | 0.83% | 3,133,175 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $13.9M | 0.82% | 1,000,604 | Common | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $13.6M | 0.80% | 427,816 | Common | SOLE |
| 877619106 | TSHA | TAYSHA GENE THERAPIES INC | $13.3M | 0.78% | 2,979,429 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $13.3M | 0.78% | 228,899 | Common | SOLE |
| 869367201 | STRO | SUTRO BIOPHARMA INC | $13.1M | 0.77% | 524,441 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $13.0M | 0.77% | 133,893 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $12.9M | 0.76% | 329,540 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $12.6M | 0.74% | 185,699 | Common | SOLE |
| 78468R663 | BIL | SPDR SERIES TRUST | $12.4M | 0.73% | 135,585 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $12.1M | 0.71% | 213,473 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $12.1M | 0.71% | 1,582,987 | Common | SOLE |
| 46124U107 | IVA | INVENTIVA SA | $12.1M | 0.71% | 2,174,398 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $12.0M | 0.71% | 160,338 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $11.6M | 0.68% | 161,252 | Common | SOLE |
| 45719W205 | IKT | INHIBIKASE THERAPEUTICS INC | $11.1M | 0.65% | 6,606,572 | Common | SOLE |
| 82835W108 | SPRY | ARS PHARMACEUTICALS INC | $10.9M | 0.64% | 1,361,536 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $10.5M | 0.62% | 200,000 | CALL | SOLE |
| G4444S107 | HLXC | HELIX ACQUISITION CORP III | $10.3M | 0.61% | 1,000,000 | Common | SOLE |
| 690469101 | OVID | OVID THERAPEUTICS INC | $10.1M | 0.59% | 4,544,113 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $10.1M | 0.59% | 2,434,941 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $9.4M | 0.55% | 12,154 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $8.5M | 0.50% | 457,137 | Common | SOLE |
| 52886X107 | LXEO | LEXEO THERAPEUTICS INC | $8.4M | 0.50% | 1,467,350 | Common | SOLE |
| 67577R102 | IRD | OPUS GENETICS INC | $8.4M | 0.50% | 1,849,004 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $8.1M | 0.48% | 268,391 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $8.0M | 0.47% | 1,464,535 | Common | SOLE |
| 56565P103 | MPLT | MAPLIGHT THERAPEUTICS INC | $7.6M | 0.45% | 374,909 | Common | SOLE |
| 04746L203 | LONA | LEONABIO INC | $7.5M | 0.44% | 727,481 | Common | SOLE |
| 29446K106 | EQ | EQUILLIUM INC | $7.5M | 0.44% | 3,726,659 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $7.4M | 0.44% | 227,717 | Common | SOLE |
| 36322Q206 | DMRA | DAMORA THERAPEUTICS INC | $7.2M | 0.43% | 279,000 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $7.1M | 0.42% | 395,459 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $7.0M | 0.41% | 94,292 | Common | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $6.9M | 0.40% | 1,973,282 | Common | SOLE |
| 464287655 | IWM | ISHARES TR | $6.8M | 0.40% | 27,500 | PUT | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $6.7M | 0.40% | 15,075 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $6.1M | 0.36% | 540,054 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $6.0M | 0.35% | 304,422 | Common | SOLE |
| 235851102 | DHR | DANAHER CORP DEL | $5.9M | 0.35% | 30,932 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $5.8M | 0.34% | 35,392 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $5.7M | 0.34% | 25,014 | Common | SOLE |
| 10922N103 | BHF | BRIGHTHOUSE FINL INC | $5.7M | 0.34% | 95,523 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $5.7M | 0.34% | 262,058 | Common | SOLE |
| G6717R120 | OACCU | OAKTREE ACQUISITION CORP III | $5.5M | 0.32% | 516,482 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $5.5M | 0.32% | 499,581 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $5.2M | 0.30% | 20,014 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $5.1M | 0.30% | 2,156,334 | Common | SOLE |
| 00534A102 | IVVD | INVIVYD INC | $5.0M | 0.29% | 3,822,427 | Common | SOLE |
| 10806XAD4 | BBIO 2.25 02/01/29 | BRIDGEBIO PHARMA INC | $4.9M | 0.29% | 45,000 | Common | SOLE |
| G1R59W127 | BHAVU | BHAV ACQUISITION CORP | $4.9M | 0.29% | 495,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $4.9M | 0.29% | 940,512 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX SA | $4.9M | 0.29% | 44,000 | CALL | SOLE |
| 10806XAJ1 | BBIO 1.75 03/01/31 | BRIDGEBIO PHARMA INC | $4.9M | 0.29% | 30,000 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $4.8M | 0.28% | 140,672 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $4.7M | 0.27% | 5,060 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $4.6M | 0.27% | 55,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $4.4M | 0.26% | 70,300 | Common | SOLE |
| 07782B104 | BLTE | BELITE BIO INC | $4.3M | 0.25% | 26,880 | Common | SOLE |
| 30054Y107 | EVMN | EVOMMUNE INC | $4.2M | 0.25% | 184,062 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.2M | 0.25% | 154,686 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $4.1M | 0.24% | 298,546 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $4.1M | 0.24% | 597,662 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $4.0M | 0.23% | 2,264,845 | Common | SOLE |
| G0273J101 | AEXA | AMERICAN EXCEPTIONALISM ACQU | $3.9M | 0.23% | 357,539 | Common | SOLE |
| 85209E208 | SPRB | SPRUCE BIOSCIENCES INC | $3.8M | 0.23% | 58,600 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $3.8M | 0.22% | 118,623 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $3.8M | 0.22% | 100,000 | PUT | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $3.8M | 0.22% | 630,403 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $3.7M | 0.22% | 32,084 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $3.6M | 0.21% | 276,661 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $3.6M | 0.21% | 20,000 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $3.5M | 0.21% | 215,752 | Common | SOLE |
| 07725L102 | ONC | BEONE MEDICINES LTD | $3.5M | 0.20% | 11,701 | Common | SOLE |
| 88032L605 | TENX | TENAX THERAPEUTICS INC | $3.4M | 0.20% | 213,462 | Common | SOLE |
| 04272N102 | AVBP | ARRIVENT BIOPHARMA INC | $3.3M | 0.19% | 141,814 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $3.3M | 0.19% | 2,585,126 | Common | SOLE |
| 04650F101 | ATAI | ATAIBECKLEY INC | $3.2M | 0.19% | 913,242 | Common | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $3.1M | 0.19% | 451,918 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $3.1M | 0.18% | 749,335 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $3.1M | 0.18% | 331,781 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $3.0M | 0.18% | 974,421 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $3.0M | 0.18% | 105,528 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $2.9M | 0.17% | 72,500 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $2.9M | 0.17% | 90,599 | Common | SOLE |
| 713317105 | PEPG | PEPGEN INC | $2.8M | 0.17% | 1,607,638 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $2.8M | 0.16% | 90,593 | Common | SOLE |
| 574795100 | MASI | MASIMO CORP | $2.7M | 0.16% | 15,000 | Common | SOLE |
| 45773H409 | INO | INOVIO PHARMACEUTICALS INC | $2.6M | 0.15% | 1,470,108 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $2.5M | 0.15% | 21,186 | Common | SOLE |
| 10919W405 | DRUG | BRIGHT MINDS BIOSCIENCES INC | $2.5M | 0.15% | 33,900 | Common | SOLE |
| 09077V100 | BIOA | BIOAGE LABS INC | $2.4M | 0.14% | 135,560 | Common | SOLE |
| 014442107 | ALEC | ALECTOR INC | $2.3M | 0.13% | 1,050,000 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $2.2M | 0.13% | 77,400 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $2.1M | 0.12% | 224,385 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $2.0M | 0.12% | 11,000 | Common | SOLE |
| G23549101 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $1.9M | 0.11% | 742,400 | Common | SOLE |
| 78464A870 | XBI | SPDR SERIES TRUST | $1.9M | 0.11% | 15,000 | PUT | SOLE |
| 86627T108 | SMMT | SUMMIT THERAPEUTICS INC | $1.7M | 0.10% | 91,869 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $1.7M | 0.10% | 20,100 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $1.6M | 0.10% | 46,400 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.6M | 0.10% | 100,000 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $1.6M | 0.09% | 46,830 | Common | SOLE |
| G2254C105 | CCIIU | COHEN CIRCLE ACQUISIT CORP I | $1.6M | 0.09% | 150,000 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $1.5M | 0.09% | 432,500 | Common | SOLE |
| 868459108 | SUPN | SUPERNUS PHARMACEUTICALS | $1.5M | 0.09% | 29,642 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $1.5M | 0.09% | 38,566 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTIC | $1.5M | 0.09% | 105,000 | Common | SOLE |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $1.5M | 0.09% | 50,095 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $1.5M | 0.09% | 5,501 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $1.4M | 0.08% | 1,205,447 | Common | SOLE |
| 34986A104 | FWRD | FORWARD AIR CORP | $1.3M | 0.08% | 78,241 | Common | SOLE |
| 81725T100 | SXT | SENSIENT TECHNOLOGIES CORP | $1.3M | 0.08% | 15,000 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $1.3M | 0.08% | 26,913 | Common | SOLE |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $1.3M | 0.08% | 87,901 | Common | SOLE |
| 80401L803 | MSLE | SATELLOS BIOSCIENCE INC | $1.3M | 0.07% | 222,555 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.2M | 0.07% | 76,206 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $1.2M | 0.07% | 33,000 | Common | SOLE |
| 74346M505 | PMN | PROMIS NEUROSCIENCES INC | $1.2M | 0.07% | 95,350 | Common | SOLE |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $1.2M | 0.07% | 750,000 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $1.2M | 0.07% | 101,500 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $1.1M | 0.07% | 205,200 | CALL | SOLE |
| 98401F105 | XNCR | XENCOR INC | $1.1M | 0.07% | 93,665 | Common | SOLE |
| 68218J103 | OABI | OMNIAB INC | $1.1M | 0.07% | 705,190 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $1.1M | 0.06% | 116,712 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $1.1M | 0.06% | 97,318 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $1.1M | 0.06% | 49,923 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $1.1M | 0.06% | 17,500 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.0M | 0.06% | 50,000 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $1.0M | 0.06% | 1,507,800 | Common | SOLE |
| G1069P137 | BSAAU | BEST SPAC I ACQUISITION CORP | $1.0M | 0.06% | 100,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $1.0M | 0.06% | 1,200 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $1.0M | 0.06% | 18,200 | Common | SOLE |
| 04280AAC4 | ARWR 0 01/15/32 | ARROWHEAD PHARMACEUTICALS IN | $1.0M | 0.06% | 10,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $1.0M | 0.06% | 20,840 | Common | SOLE |
| 285512109 | EA | ELECTRONIC ARTS INC | $1.0M | 0.06% | 4,936 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.0M | 0.06% | 130,560 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $999,600 | 0.06% | 105,000 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $923,700 | 0.05% | 10,000 | Common | SOLE |
| G2545C104 | CBIO | CRESCENT BIOPHARMA INC. | $923,515 | 0.05% | 50,273 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $919,866 | 0.05% | 351,094 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $910,402 | 0.05% | 133,686 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $907,267 | 0.05% | 172,157 | Common | SOLE |
| 015271109 | ARE | ALEXANDRIA REAL ESTATE EQ IN | $905,190 | 0.05% | 19,500 | Common | SOLE |
| G52443119 | KVAC | KEEN VISION ACQUISITION CORP | $900,000 | 0.05% | 75,000 | CALL | SOLE |
| 451033708 | IBIO | IBIO INC | $892,768 | 0.05% | 469,878 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $888,800 | 0.05% | 10,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $885,139 | 0.05% | 6,351 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $869,085 | 0.05% | 56,070 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $860,504 | 0.05% | 47,463 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $843,612 | 0.05% | 1,830 | Common | SOLE |
| 00704R109 | ANL | ADLAI NORTYE LTD | $815,930 | 0.05% | 117,909 | Common | SOLE |
| 98262P200 | WW | WW INTL INC | $792,798 | 0.05% | 57,700 | Common | SOLE |
| 04965N104 | RNA | ATRIUM THERAPEUTICS INC | $771,000 | 0.05% | 57,688 | Common | SOLE |
| 45826H109 | ITGR | INTEGER HLDGS CORP | $770,000 | 0.05% | 8,750 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $765,000 | 0.05% | 100,000 | CALL | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $761,620 | 0.04% | 136,736 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $735,310 | 0.04% | 139,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $711,208 | 0.04% | 6,942 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $710,500 | 0.04% | 50,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $666,400 | 0.04% | 20,000 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $654,000 | 0.04% | 1,428,571 | CALL | SOLE |
| 29251M106 | ENTA | ENANTA PHARMACEUTICALS INC | $648,639 | 0.04% | 51,357 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $645,008 | 0.04% | 16,033 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $635,680 | 0.04% | 1,063,899 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $627,500 | 0.04% | 10,000 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $627,200 | 0.04% | 80,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $610,465 | 0.04% | 57,591 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $607,943 | 0.04% | 81,933 | Common | SOLE |
| 482929106 | KLRS | KALARIS THERAPEUTICS INC | $577,000 | 0.03% | 100,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $572,756 | 0.03% | 6,200 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $567,150 | 0.03% | 3,000 | Common | SOLE |
| 045396207 | ASMB | ASSEMBLY BIOSCIENCES INC | $553,529 | 0.03% | 19,947 | Common | SOLE |
| 74065P101 | PRLD | PRELUDE THERAPEUTICS INC | $522,662 | 0.03% | 152,825 | Common | SOLE |
| G3933N108 | GTERU | GLOBA TERRA ACQUISITION COR | $518,000 | 0.03% | 50,000 | Common | SOLE |
| 97717Y527 | USFR | WISDOMTREE TR | $503,400 | 0.03% | 10,000 | Common | SOLE |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $496,598 | 0.03% | 132,426 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $483,285 | 0.03% | 1,500 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $483,101 | 0.03% | 374,497 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $478,600 | 0.03% | 20,000 | Common | SOLE |
| 670100205 | NVO | NOVO-NORDISK A S | $477,750 | 0.03% | 13,000 | CALL | SOLE |
| 71722W107 | PHAT | PHATHOM PHARMACEUTICALS INC | $476,619 | 0.03% | 42,900 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $468,506 | 0.03% | 895 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $455,301 | 0.03% | 103,950 | Common | SOLE |
| 01609W102 | BABA | ALIBABA GROUP HLDG LTD | $448,896 | 0.03% | 3,578 | Common | SOLE |
| 21874A106 | CORZ | CORE SCIENTIFIC INC NEW | $448,800 | 0.03% | 30,000 | Common | SOLE |
| 00032Q104 | WHWK | WHITEHAWK THERAPEUTICS INC | $443,335 | 0.03% | 128,503 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $429,379 | 0.03% | 2,147 | Common | SOLE |
| 92840H400 | VTGN | VISTAGEN THERAPEUTICS INC | $429,277 | 0.03% | 751,141 | Common | SOLE |
| 88338N206 | TXMD | THERAPEUTICSMD INC | $422,604 | 0.02% | 209,210 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $419,000 | 0.02% | 20,000 | CALL | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $408,800 | 0.02% | 17,500 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $401,861 | 0.02% | 13,001 | Common | SOLE |
| 29384C108 | TRDA | ENTRADA THERAPEUTICS INC | $384,910 | 0.02% | 30,500 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $378,813 | 0.02% | 44,777 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $377,711 | 0.02% | 3,140 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $376,830 | 0.02% | 71,100 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $372,800 | 0.02% | 20,000 | CALL | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $372,206 | 0.02% | 44,416 | Common | SOLE |
| 007002207 | ACET | ADICET BIO INC | $366,562 | 0.02% | 53,827 | Common | SOLE |
| 52490G102 | LEGN | LEGEND BIOTECH CORP | $361,800 | 0.02% | 20,000 | Common | SOLE |
| 86889P208 | SRZN | SURROZEN INC | $349,560 | 0.02% | 12,000 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $338,448 | 0.02% | 144,636 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $330,823 | 0.02% | 71,298 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $329,350 | 0.02% | 2,500 | Common | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $328,650 | 0.02% | 35,000 | CALL | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $325,525 | 0.02% | 44,900 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $325,200 | 0.02% | 40,000 | Common | SOLE |
| 49721T507 | KPRX | KIORA PHARMACEUTICALS INC | $324,126 | 0.02% | 167,941 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $322,480 | 0.02% | 8,000 | Common | SOLE |
| 91678A107 | UPB | UPSTREAM BIO INC | $315,000 | 0.02% | 35,000 | Common | SOLE |
| 68752L100 | KIDS | ORTHOPEDIATRICS CORP | $314,940 | 0.02% | 19,845 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $304,700 | 0.02% | 55,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $298,000 | 0.02% | 200,000 | Common | SOLE |
| 47215P106 | JD | JD.COM INC | $295,700 | 0.02% | 10,000 | Common | SOLE |
| 69353Y103 | PMVP | PMV PHARMACEUTICALS INC | $286,450 | 0.02% | 231,008 | Common | SOLE |
| 68232V884 | TRAW | TRAWS PHARMA INC | $281,999 | 0.02% | 154,098 | Common | SOLE |
| 008064206 | JBIO | JADE BIOSCIENCES INC | $281,000 | 0.02% | 20,000 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $280,730 | 0.02% | 13,400 | Common | SOLE |
| G7257A113 | PCAPU | PROCAP ACQUISITION CORP | $278,560 | 0.02% | 26,940 | Common | SOLE |
| 055477103 | BCAX | BICARA THERAPEUTICS INC | $272,592 | 0.02% | 13,705 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $266,420 | 0.02% | 43,250 | Common | SOLE |
| 697435105 | PANW | PALO ALTO NETWORKS INC | $256,512 | 0.02% | 1,600 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $250,208 | 0.01% | 19,517 | Common | SOLE |
| 22788C105 | CRWD | CROWDSTRIKE HLDGS INC | $249,862 | 0.01% | 640 | Common | SOLE |
| 781154109 | RBRK | RUBRIK INC. | $239,953 | 0.01% | 4,900 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $239,850 | 0.01% | 5,000 | Common | SOLE |
| 86881A100 | SGRY | SURGERY PARTNERS INC | $238,400 | 0.01% | 20,000 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $237,353 | 0.01% | 52,745 | Common | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $229,580 | 0.01% | 55,859 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $224,700 | 0.01% | 35,000 | Common | SOLE |
| 54303L203 | LGVN | LONGEVERON INC | $208,000 | 0.01% | 200,000 | Common | SOLE |
| 032724106 | ANAB | ANAPTYSBIO INC | $205,091 | 0.01% | 3,698 | Common | SOLE |
| G1828R101 | CEPS | CANTOR EQUITY PARTNERS VI IN | $202,000 | 0.01% | 20,000 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $201,300 | 0.01% | 10,000 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $193,554 | 0.01% | 22,428 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $186,615 | 0.01% | 43,500 | Common | SOLE |
| 08205P209 | BNTC | BENITEC BIOPHARMA INC | $186,375 | 0.01% | 17,500 | Common | SOLE |
| 53630X203 | LPCN | LIPOCINE INC NEW | $185,208 | 0.01% | 23,180 | Common | SOLE |
| 75120L209 | RLYB | RALLYBIO CORP | $184,199 | 0.01% | 20,535 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $178,971 | 0.01% | 58,679 | Common | SOLE |
| 62856X300 | QCLS | Q/C TECHNOLOGIES INC | $172,500 | 0.01% | 50,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $161,800 | 0.01% | 10,000 | Common | SOLE |
| 22407B108 | COYA | COYA THERAPEUTICS INC | $161,146 | 0.01% | 40,900 | Common | SOLE |
| 71535D106 | PSNL | PERSONALIS INC | $159,250 | 0.01% | 25,000 | Common | SOLE |
| 825704109 | SIBN | SI BONE INC | $158,885 | 0.01% | 12,580 | Common | SOLE |
| 68236X100 | TOI | THE ONCOLOGY INSTITUTE INC | $153,500 | 0.01% | 50,000 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $150,134 | 0.01% | 31,278 | Common | SOLE |
| 64131A105 | STIM | NEURONETICS INC | $145,000 | 0.01% | 100,000 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $143,161 | 0.01% | 23,900 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $141,558 | 0.01% | 158,271 | Common | SOLE |
| 004468500 | ACHV | ACHIEVE LIFE SCIENCE INC | $140,532 | 0.01% | 47,800 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $135,100 | 0.01% | 35,000 | Common | SOLE |
| 16385C203 | CMMB | CHEMOMAB THERAPEUTICS LTD | $125,600 | 0.01% | 80,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $122,668 | 0.01% | 140,000 | Common | SOLE |
| 64136E102 | NEUP | NEUPHORIA THERAPEUTICS INC | $122,100 | 0.01% | 30,000 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $119,000 | 0.01% | 100,000 | Common | SOLE |
| 03969T109 | ARCT | ARCTURUS THERAPEUTICS HLDGS | $115,800 | 0.01% | 15,000 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $115,600 | 0.01% | 40,000 | Common | SOLE |
| 12529R107 | CCCC | C4 THERAPEUTICS INC | $113,090 | 0.01% | 43,000 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $107,450 | 0.01% | 35,000 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $106,400 | 0.01% | 10,000 | Common | SOLE |
| 38341P102 | GOSS | GOSSAMER BIO INC | $94,454 | 0.01% | 287,531 | Common | SOLE |
| 45258H106 | IMMX | IMMIX BIOPHARMA INC | $91,100 | 0.01% | 10,000 | Common | SOLE |
| 834212201 | STI | SOLIDION TECHNOLOGY INC | $85,185 | 0.01% | 13,500 | CALL | SOLE |
| 55279B301 | LITS | LITE STRATEGY INC | $78,059 | 0.00% | 67,292 | Common | SOLE |
| 92536C202 | VERU | VERU INC | $77,350 | 0.00% | 35,000 | Common | SOLE |
| 31572Q881 | KYNB | KYNTRA BIO INC | $70,980 | 0.00% | 10,469 | Common | SOLE |
| 18914F103 | CLOV | CLOVER HEALTH INVESTMENTS CO | $70,400 | 0.00% | 40,000 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $66,433 | 0.00% | 43,420 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $64,545 | 0.00% | 33,100 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $59,900 | 0.00% | 10,000 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC NE | $58,636 | 0.00% | 21,400 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $49,500 | 0.00% | 150,000 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $47,405 | 0.00% | 13,861 | Common | SOLE |
| G0544A145 | ASPCR | A SPAC III ACQUISITION CORP | $42,441 | 0.00% | 215,000 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $41,500 | 0.00% | 10,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $39,534 | 0.00% | 50,685 | Common | SOLE |
| 09077B104 | BCABGBP | BIOATLA INC | $36,725 | 0.00% | 228,107 | Common | SOLE |
| 483119202 | KALAEUR | KALA BIO INC | $24,490 | 0.00% | 141,480 | Common | SOLE |
| 19249H103 | CHRS | COHERUS ONCOLOGY INC | $17,519 | 0.00% | 10,366 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $16,200 | 0.00% | 10,000 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $5,080 | 0.00% | 50,100 | Common | SOLE |
| 22053A107 | — | QUINCE THERAPEUTICS INC | $5,070 | 0.00% | 50,000 | PUT | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $0 | — | 30,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.